314 related articles for article (PubMed ID: 16450574)
1. Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis.
Chervinsky P; Nayak A; Rooklin A; Danzig M
Allergy Asthma Proc; 2005; 26(5):391-6. PubMed ID: 16450574
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
Pleskow W; Grubbe R; Weiss S; Lutsky B
Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis.
Grubbe RE; Lumry WR; Anolik R
J Investig Allergol Clin Immunol; 2009; 19(2):117-24. PubMed ID: 19476015
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of once-daily desloratadine/pseudoephedrine for relief of nasal congestion.
Schenkel E; Corren J; Murray JJ
Allergy Asthma Proc; 2002; 23(5):325-30. PubMed ID: 12476542
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
Berger WE; Schenkel EJ; Mansfield LE;
Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
[TBL] [Abstract][Full Text] [Related]
6. Desloratadine and pseudoephedrine combination therapy as a comprehensive treatment for allergic rhinitis and nasal congestion.
Anolik R
Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):683-94. PubMed ID: 19473112
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis.
Bronsky E; Boggs P; Findlay S; Gawchik S; Georgitis J; Mansmann H; Sholler L; Wolfe J; Meltzer E; Morris R
J Allergy Clin Immunol; 1995 Aug; 96(2):139-47. PubMed ID: 7636050
[TBL] [Abstract][Full Text] [Related]
8. 24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139].
Salmun LM; Lorber R
BMC Fam Pract; 2002 Aug; 3():14. PubMed ID: 12162793
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
Berger WE; White MV;
Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis.
Raphael GD; Angello JT; Wu MM; Druce HM
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):606-14. PubMed ID: 16680933
[TBL] [Abstract][Full Text] [Related]
12. Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge.
Georgitis JW; Meltzer EO; Kaliner M; Weiler J; Berkowitz R
Ann Allergy Asthma Immunol; 2000 Apr; 84(4):451-9. PubMed ID: 10795655
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: results of a Canadian multicenter, open-label trial.
Keith PK; Luciuk G
Clin Ther; 2007 Mar; 29(3):419-26. PubMed ID: 17577463
[TBL] [Abstract][Full Text] [Related]
14. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
Horak F; Zieglmayer UP; Zieglmayer R; Kavina A; Marschall K; Munzel U; Petzold U
Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
[TBL] [Abstract][Full Text] [Related]
15. SCH 434: a new antihistamine/decongestant for seasonal allergic rhinitis.
Storms WW; Bodman SF; Nathan RA; Chervinsky P; Banov CH; Dockhorn RJ; Jarmoszuk I; Zeitz HJ; McGeady SJ; Pinnas JL
J Allergy Clin Immunol; 1989 Jun; 83(6):1083-90. PubMed ID: 2471718
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis.
Sussman GL; Mason J; Compton D; Stewart J; Ricard N
J Allergy Clin Immunol; 1999 Jul; 104(1):100-6. PubMed ID: 10400846
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure.
Horak F; Stübner P; Zieglmeyer R; Harris AG
Allergy; 2003 Jun; 58(6):481-5. PubMed ID: 12757447
[TBL] [Abstract][Full Text] [Related]
18. [Nasal budesonide plus zafirlukast vs nasal budesonide plus loratadine-pseudoephedrine for controlling the symptoms of rhinitis and asthma].
Benitez HH; Arvizu VM; Gutiérrez DJ; Fogelbach GA; Castellanos Olivares A; Vázquez Nava F; Velázquez HC; González Pérez Mdel C; Mora Nieto A; Rodríguez EC
Rev Alerg Mex; 2005; 52(2):90-5. PubMed ID: 16158782
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy and safety of once-daily versus twice-daily loratadine-pseudoephedrine combinations versus placebo in seasonal allergic rhinitis.
Kaiser HB; Banov CH; Berkowitz RR; Bernstein DI; Bronsky EA; Georgitis JW; Mendelson LM; Rooklin AR; Sholler LJ; Stricker WW; Harrison JE; Danzig MR; Lorber RR
Am J Ther; 1998 Jul; 5(4):245-51. PubMed ID: 10099066
[TBL] [Abstract][Full Text] [Related]
20. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
